{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:20:18Z","timestamp":1791379218574,"version":"4.3.2"},"reference-count":61,"publisher":"MedWorks Media","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacol Bull"],"abstract":"<jats:p>Alteplase is the main pharmacological treatment available for intravenous thrombolysis in patients with acute ischemic stroke. Endovascular treatment alone or add-on to intravenous thrombolysis is a valid approach in acute ischemic stroke with cerebral large vessel disease. The most common serious adverse reaction related to alteplase is the development of spontaneous intracerebral hemorrhage and the presence of cerebral small vessel disease may increase this risk, particularly in cocaine users, even if only few data have been published on this topic. Here we reviewed in cocaine users with acute ischemic stroke the efficacy and safety of thrombolytic therapy.<\/jats:p>","DOI":"10.64719\/pb.4583","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:39:16Z","timestamp":1761046756000},"page":"70-79","source":"Crossref","is-referenced-by-count":1,"title":["Thrombolytic Therapy in Cocaine Users with Ischemic Stroke: A Review of Current Practice"],"prefix":"10.64719","volume":"49","author":[{"given":"Antonio","family":"Siniscalchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista De","family":"Sarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Pacifici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermanno","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Sanguigni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Gallelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54175","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Cheng YC, Ryan KA, Qadwai SA et al. Cocaine Use and Risk of Ischemic Stroke in Young Adults. Stroke. 2016;47(4):918\u2013922.","DOI":"10.1161\/STROKEAHA.115.011417"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Siniscalchi A, Bonci A, Mercuri NB et al. Cocaine dependence and stroke: pathogenesis and management. Curr Neurovasc Res. 2015;12(2):163\u2013172.","DOI":"10.2174\/1567202612666150305110144"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"de Souza A, Desai PK, de Souza RJ. Acute multifocal neuropathy following cocaine inhalation. J Clin Neurosci. 2017;36:134\u2013136.","DOI":"10.1016\/j.jocn.2016.10.015"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Desai R, Patel U, Rupareliya C et al. Impact of Cocaine Use on Acute Ischemic Stroke Patients: Insights from Nationwide Inpatient Sample in the United States. Cureus. 2017;9(8):e1536.","DOI":"10.7759\/cureus.1536"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Nolte KB, Brass LM, Fletterick CF. Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology. 1996;46(5):1291\u20131296.","DOI":"10.1212\/WNL.46.5.1291"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Levine SR, Brust JCM, Futrell N et al. Cerebrovascular Complications of the Use of the Crack Form of Alkaloidal Cocaine. N Engl J Med. 1990;323(11):699\u2013704.","DOI":"10.1056\/NEJM199009133231102"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Schwartz BG, Rezkalla S, Kloner RA. Cardiovascular Effects of Cocaine. Circulation. 2010;122(24):2558\u20132569.","DOI":"10.1161\/CIRCULATIONAHA.110.940569"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Bhattacharya P, Taraman S, Shankar L, Chaturvedi S, Madhavan R. Clinical profiles, complications, and disability in cocaine-related ischemic stroke. J Stroke Cerebrovas Dis. 2011;20(5):443\u2013449.","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.02.017"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Toossi S, Hess CP, Hills NK, Josephson SA. Neurovascular Complications of Cocaine Use at a Tertiary Stroke Center. J Stroke Cerebrovasc. 2010;19(4):273\u2013278.","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.05.002"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Sanchez-Ramos J. Neurologic Complications of Psychomotor Stimulant Abuse. Inter Rev Neurobiol. 2015;120:131\u2013160.","DOI":"10.1016\/bs.irn.2015.02.003"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Vilela LR, Gomides LF, David BA et al. Cannabidiol rescues acute hepatic toxicity and seizure induced by cocaine. Mediators Inflamm. 2015;2015:523418.","DOI":"10.1155\/2015\/523418"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Anticoli S, Pezzella FR, Pozzessere C et al. Transient Ischemic Attack Fast-track and Long-Term Stroke Risk: Role of Diffusion-Weighted Magnetic Resonance Imaging. J Stroke Cerebrovas Dis. 2015;24(9):2110\u20132116.","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.05.016"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia \u2013 the ischemic penumbra. Stroke. 1981;12(6):723\u2013725.","DOI":"10.1161\/01.STR.12.6.723"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Siniscalchi A, Sztajzel R, Malferrari G, Gallelli L. The National Institutes of Health Stroke Scale: Its Role in Patients with Posterior Circulation Stroke. Hospital Top. 2017;95(4):79\u201381.","DOI":"10.1080\/00185868.2017.1322888"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Siniscalchi A, Lochner P, Perrotta P et al. Isolated Hand Palsy in National Institutes of Health Stroke Scale (NIHSS): Is It Useful? West J Emerg Med. 2018;19(3):524\u2013526.","DOI":"10.5811\/westjem.2018.2.37654"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Pezzella FR, Pozzessere C, Siniscalchi A et al. The cloud stroke unit: 24-hour acute stroke expertise-on-demand. Hospital Top. 2013;91(4):81\u201386.","DOI":"10.1080\/00185868.2013.848160"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol. 1994;36(4):557\u201365.","DOI":"10.1002\/ana.410360404"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Sharp FR, Lu A, Tang Y, Millhorn DE. Multiple molecular penumbras after focal cerebral ischemia. J Stroke Cerebrovas Dis. 2000;20(7):1011\u20131032.","DOI":"10.1097\/00004647-200007000-00001"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Micieli G, Marcheselli S, Tosi PA. Safety and efficacy of alteplase in the treatment of acute ischemic stroke. Vasc Health Risk Manag. 2009;5(1):397\u2013409.","DOI":"10.2147\/VHRM.S4561"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Jahan R, Vinuela F. Treatment of acute ischemic stroke: intravenous and endovascular therapies. Expert Rev Cardiovasc Ther. 2009;7(4):375\u2013387.","DOI":"10.1586\/erc.09.13"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Davis SM, Donnan GA, Parsons MW et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. The Lancet Neurology. 2008;7(4):299\u2013309.","DOI":"10.1016\/S1474-4422(08)70044-9"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Kleindorfer D, Kissela B, Schneider A et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke. 2004;35(2):e27\u20139.","DOI":"10.1161\/01.STR.0000109767.11426.17"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Cheng NT, Kim AS. Intravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours Versus Between 3 and 4.5 Hours of Symptom Onset. Neurohospitalist. 2015;5(3):101\u2013109.","DOI":"10.1177\/1941874415583116"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Lehman LL, Kleindorfer DO, Khoury JC et al. Potential eligibility for recombinant tissue plasminogen activator therapy in children: a population-based study. J Child Neurol. 2011;26(9):1121\u20131125.","DOI":"10.1177\/0883073811408091"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Hacke W, Donnan G, Fieschi C et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363(9411):768\u2013774.","DOI":"10.1016\/S0140-6736(04)15692-4"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Bush CK, Kurimella D, Cross LJ et al. Endovascular Treatment with Stent-Retriever Devices for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials. PLoS One. 2016;11(1):e0147287.","DOI":"10.1371\/journal.pone.0147287"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Goyal M, Demchuk AM, Menon BK et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019\u20131030.","DOI":"10.1056\/NEJMoa1414905"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Berkhemer OA, Fransen PS, Beumer D et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11\u201320.","DOI":"10.1056\/NEJMoa1411587"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Dorado L, Millan M, Davalos A. Reperfusion therapies for acute ischemic stroke: an update. Curr Cardiol Rev. 2014;10(4):327\u2013335.","DOI":"10.2174\/1573403X10666140320144637"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Pierot L, Soize S, Benaissa A, Wakhloo AK. Techniques for endovascular treatment of acute ischemic stroke: from intra-arterial fibrinolytics to stent-retrievers. Stroke. 2015;46(3):909\u2013914.","DOI":"10.1161\/STROKEAHA.114.007935"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Vidale S, Peroni R, Di Palma F et al. Intra-arterial thrombolysis in a young patient with cocaine-associated stroke. Neurol Sci. 2014;35(9):1465\u20131466.","DOI":"10.1007\/s10072-014-1779-4"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Rodrigues FB, Neves JB, Caldeira D et al. Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis. BMJ. 2016;353:i1754.","DOI":"10.1136\/bmj.i1754"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Bracard S, Ducrocq X, Guillemin F et al. Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke \u2013 Authors\u2019 reply. Lancet Neurol. 2017;16(2):104.","DOI":"10.1016\/S1474-4422(16)30378-7"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Bracard S, Ducrocq X, Mas JL et al. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 2016;15(11):1138\u201347.","DOI":"10.1016\/S1474-4422(16)30177-6"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Desai SM, Haussen DC, Aghaebrahim A et al. Thrombectomy 24 hours after stroke: beyond DAWN. J NeuroInterv Surg. 2018 May 28;","DOI":"10.1136\/neurintsurg-2018-013923"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Jovin TG, Nogueira RG. Thrombectomy 6 to 24 Hours after Stroke. N Engl J Med. 2018;378(12):1161\u20132.","DOI":"10.1056\/NEJMc1801530"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Nogueira RG, Jadhav AP, Haussen DC et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378(1):11\u201321.","DOI":"10.1056\/NEJMoa1706442"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Albers GW, Marks MP, Kemp S et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378(8):708\u2013718.","DOI":"10.1056\/NEJMoa1713973"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Vidale S, Agostoni E. Endovascular Treatment of Ischemic Stroke: An Updated Meta-Analysis of Efficacy and Safety. Vasc Endovasc Surg. 2017;51(4):215\u2013219.","DOI":"10.1177\/1538574417698905"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Coutinho JM, Liebeskind DS, Slater LA et al. Combined Intravenous Thrombolysis and Thrombectomy vs Thrombectomy Alone for Acute Ischemic Stroke: A Pooled Analysis of the SWIFT and STAR Studies. JAMA Neurol. 2017;74(3):268\u2013274.","DOI":"10.1001\/jamaneurol.2016.5374"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Al-Khaled M, Bruning T, Gottwald C et al. Comparing outcome and recanalization results in patients with anterior circulation stroke following endovascular treatment with and without a treatment with rt-PA: A single-center study. Brain Behav. 2018;8(5):e00974.","DOI":"10.1002\/brb3.974"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Sussman ES, Connolly ES., Jr. Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke. Front Neurol. 2013;4:69.","DOI":"10.3389\/fneur.2013.00069"},{"key":"ref43","unstructured":"Zhang J, Yang Y, Sun H, Xing Y. Hemorrhagic transformation after cerebral infarction: current concepts and challenges. Ann Transl Med. 2014;2(8):81."},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Jaillard A, Cornu C, Durieux A et al. Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke. 1999;30(7):1326\u20131332.","DOI":"10.1161\/01.STR.30.7.1326"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Bang OY, Saver JL, Kim SJ et al. Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke. 2011;42(8):2235\u20132239.","DOI":"10.1161\/STROKEAHA.110.604603"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Kidwell CS, Saver JL, Carneado J et al. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke. 2002;33(3):717\u2013724.","DOI":"10.1161\/hs0302.104110"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Pantoni L, Fierini F, Poggesi A. Thrombolysis in Acute Stroke Patients with Cerebral Small Vessel Disease. Cerebrovasc Dis. 2014;37(1):5\u201313.","DOI":"10.1159\/000356796"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Charidimou A, Pasi M, Fiorelli M et al. Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1) Stroke. 2016;47(9):2364\u20132372.","DOI":"10.1161\/STROKEAHA.116.014096"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Griebe M, Fischer E, Kablau M et al. Thrombolysis in patients with lacunar stroke is safe: an observational study. J Neurol. 2014;261(2):405\u2013411.","DOI":"10.1007\/s00415-013-7212-8"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Reimann A, Li Z, Goebel S et al. Combined administration of the GPVI-Fc fusion protein Revacept with low-dose thrombolysis in the treatment of stroke. Heart Int. 2016;11(1):e10\u2013e6.","DOI":"10.5301\/heartint.5000229"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"McCord J, Jneid H, Hollander JE et al. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation. 2008;117(14):1897\u20131907.","DOI":"10.1161\/CIRCULATIONAHA.107.188950"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Hollander JE, Wilson LD, Leo PJ, Shih RD. Complications from the use of thrombolytic agents in patients with cocaine associated chest pain. J Emerg Med. 1996;14(6):731\u2013736.","DOI":"10.1016\/S0736-4679(96)00187-4"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Martin-Schild S, Albright KC, Misra V et al. Intravenous Tissue Plasminogen Activator in Patients With Cocaine-Associated Acute Ischemic Stroke. Stroke. 2009;40(11):3635\u20133637.","DOI":"10.1161\/STROKEAHA.109.559823"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"AbdelRazek MA, Gutierrez J, Mampre D et al. Intravenous Thrombolysis for Stroke and Presumed Stroke in Human Immunodeficiency Virus-Infected Adults: A Retrospective, Multicenter US Study. Stroke. 2018;49(1):228\u2013231.","DOI":"10.1161\/STROKEAHA.117.019570"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Baud MO, Brown EG, Singhal NS, Hemphill JC., 3rd Immediate Hemorrhagic Transformation After Intravenous Tissue-Type Plasminogen Activator Injection in 2 Cocaine Users. Stroke. 2015;46(7):e167\u2013e169.","DOI":"10.1161\/STROKEAHA.115.008687"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Konzen JP, Levine SR, Garcia JH. Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine. Stroke. 1995;26(6):1114\u20131118.","DOI":"10.1161\/01.STR.26.6.1114"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Vallee JN, Crozier S, Guillevin R et al. Acute basilar artery occlusion treated by thromboaspiration in a cocaine and ecstasy abuser. Neurology. 2003;61(6):839\u2013841.","DOI":"10.1212\/WNL.61.6.839"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"MacEwen C, Ward M, Buchan A. A case of cocaine-induced basilar artery thrombosis. Nat Clin Pract Neurol. 2008;4(11):622\u2013626.","DOI":"10.1038\/ncpneuro0879"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Johnson K, Noe T, Collins D, Strader T, Bucuoltz G. Mobilizing church communities to prevent alcohol and other drug abuse: a model strategy and its evaluation. J Community Pract. 2000;7:1\u201327.","DOI":"10.1300\/J125v07n02_01"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Siniscalchi A, Sztajzel R, Malferrari G et al. Editorial: Cocaine and Acute Basilar Artery Occlusion: What we Know to Date? Curr Vasc Pharmacol. 2017;15(1):3\u20134.","DOI":"10.2174\/1570161114666160909162205"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Sajja RK, Rahman S, Cucullo L. Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress. J Cerebral Blood Flow Metab. 2016;36(3):539\u2013554.","DOI":"10.1177\/0271678X15616978"}],"container-title":["Psychopharmacology Bulletin"],"original-title":[],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:34:51Z","timestamp":1791315291000},"score":1,"resource":{"primary":{"URL":"https:\/\/medworksmedia.com\/pb-article\/thrombolytic-therapy-in-cocaine-users-with-ischemic-stroke-a-review-of-current-practice\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,8,12]]}},"URL":"https:\/\/doi.org\/10.64719\/pb.4583","relation":{},"ISSN":["2472-2448"],"issn-type":[{"value":"2472-2448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}